GE announced strong second-quarter 2011 operating earnings from continuing operations of $3.7 billion, up 18%, or $0.34 per share, up 17%, from the second quarter of 2010.
Please click here to read the rest of the press release, in English.
Corporate Communications
[email protected]
business unit
tags
GE announced strong first-quarter 2011 operating earnings of $3.6 billion, up 58%, or $0.33 per share, up 65%, from the first quarter of 2010.
Please click here to read the rest of the press release, in English.
Corporate Communications
[email protected]
business unit
tags
GE announced strong fourth-quarter 2010 earnings from continuing operations (attributable to GE) of $3.9 billion, or $0.36 per share, up 33% from the fourth quarter of 2009.
Please click here to read the rest of the press release, in English.
Third Quarter Earnings
GE announced third-quarter 2010 earnings from continuing operations (attributable to GE) of $3.2 billion, with EPS of $0.29 per share up 32% from the third quarter of 2009.
Please click here to read the rest of the press release, in English.
GE announced second-quarter 2010 earnings from continuing operations (attributable to GE) of $3.3 billion, with EPS of $0.30 per share up 15% from the second quarter of 2009.
Please click here to read the rest of the press release, in English.
Corporate Communications
[email protected]
business unit
tags
GE announced that its 2009 annual report entitled Renew is now available on the Company's web site at www.ge.com/annualreport. Explore how, even in an environment of renewal, GE businesses are positioned for growth and ready to take on the world's toughest challenges.
View the 2009 Annual Report web site
Corporate Communications
[email protected]
business unit
tags
CHALFONT ST GILES, UK, 27 AUGUST 2009 - GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced that Stephen Minger, Ph.D, previously Senior Lecturer and Director of King's College London's Stem Cell Biology Laboratory, will join GE Healthcare's Life Sciences business as head of Research and Development for Cell Technologies on September 1st 2009.
